Skip to main content

Table 3 Logistic regression analyses

From: Factors influencing diagnosis and treatment of osteoporosis after a fragility fracture among postmenopausal women in Asian countries: a retrospective study

  BMD measurement (N=837) Osteoporosis diagnosis Osteoporosis medication
OR (95% CI) OR (95% CI) OR (95% CI)
Age       
 20- 49 1.38 (0.35 -5.51) 0.6 (0.18-2.00) N/A  
 50-64 1.36 (0.91-2.05) 1.19 (0.77-1.84) 0.59 (0.36-0.96)
 65+ Reference   Reference   Reference  
Fracture history       
 Yes 0.63 (0.45-0.88) 0.80 (0.56-1.15) 1.05 (0.71-1.54)
 No Reference   Reference   Reference  
Fracture diagnosis timing       
 Before index fracture N/A   N/A   0.99 (0.64-1.52)
 During index fracture N/A   N/A   1.38 (0.87-2.18)
 After index fracture N/A   N/A   Reference  
 Unknown N/A   N/A   0.28 (0.05-1.47)
A BMD measurement       
 Yes N/A   10.1 (6.36-16.0) 1.79 (1.23-2.61)
 Unknown N/A   0.06 (0.03-0.10 1.48 (0.59-3.74)
 No N/A   Reference   Reference  
Type of payment       
 100% private insurance 8.19 (2.63 -25.58) 0.72 (0.20-2.54) 2.03 (0.54-7.66)
 100% social insurance 1.96 (1.09 -3.50) 0.47 (0.27-0.84) 0.18 (0.07-0.51)
 Other type of insurance 5.08 (3.11 -8.30) 2.48 (1.45-4.25) 2.45 (1.40-4.29)
 Unknown insurance 1.33 (0.62-2.83) 0.39 (0.19-0.80) 1.05 (0.38-2.92)
 Free hospital, government pay 4.13 (2.00-8.54) 1.31 (0.57-3.03) 1.56 (0.66-3.70)
 Partial self with private insurance 3.43 (1.19-9.86) 4.95 (1.51-16.21) 0.49 (0.15-1.59)
 Partial self with social insurance 3.94 (2.61 -5.95) 1.89 (1.28-2.81) 0.72 (0.45-1.15)
 100% self pay Reference   Reference   Reference  
  1. N/A, not applicable.